• Skip to main content
  • Skip to secondary menu
  • Skip to footer

Defense Conferences / Aerospace & Defense Market

National Security Matters

  • Defense Events Calendar 2022-2023
  • Sponsored Post
  • Defense Market
  • About
  • Contact

Valneva: US DoD Exercises Option on IXIARO® Supply Contract Bringing Total Value to $70 Million

January 14, 2020 By DefenseConference.com

Valneva SE (“Valneva” or “the Company”), announced today that the U.S. government Department of Defense (DoD) has exercised an option to purchase 80,000 additional doses of its Japanese encephalitis (JE) vaccine IXIARO®. The option brings the total value of the contract signed with the DoD in January 20191 to $70 million. Shipments associated with the option will commence shortly.

Valneva expects to sign a new contract with the DoD during the first half of the year.

Franck Grimaud, Chief Business Officer of Valneva commented, “We thank the DoD for their renewed confidence in helping them protect military personnel and their families from Japanese encephalitis. We look forward to continuing to develop our relationship with the DoD.”

IXIARO® is the only JE vaccine approved by the U.S. Food and Drug Administration (FDA). It was developed through a cooperative research and development agreement with the Walter Reed Army Institute of Research. Valneva markets and distributes IXIARO® directly to the U.S. military and U.S. private market.

About IXIARO®/JESPECT®
Valneva’s Japanese encephalitis vaccine is indicated for active immunization for the prevention of the disease for people who travel to, or live in, endemic areas. It has received marketing approval in the U.S., Europe, Canada, Hong Kong, Singapore, and Israel under the trade name IXIARO® and in Australia and New Zealand where it is marketed as JESPECT®. It is the only vaccine available to the U.S. military for Japanese Encephalitis. IXIARO® is approved for use in individuals two months of age and older in the U.S. and EU member states, Canada, Norway, Liechtenstein, Iceland, Singapore, Hong Kong, Japan, the Republic of Korea and Israel. In all other licensed territories, IXIARO®/JESPECT® is indicated for use in persons aged 18 years or more.

About Japanese Encephalitis
Japanese encephalitis is a deadly infectious disease found mainly in Asia. About 70,000 cases of JE are estimated to occur in Asia each year, although the actual number of cases is likely much higher due to underreporting in rural areas. JE is fatal in approximately 30 percent of those who show symptoms, and leaves half of survivors with permanent brain damage. The disease is endemic in Southeast Asia, India and China, a region with a population of more than three billion. In 2005, JE killed more than 1,200 children in only one month during an epidemic outbreak in Uttar Pradesh, India, and Nepal.

About Valneva SE
Valneva is a specialty vaccine company providing prevention against diseases with major unmet medical needs. Valneva’s portfolio includes two commercial vaccines for travelers: IXIARO®/JESPECT® indicated for the prevention of Japanese encephalitis and DUKORAL® indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by ETEC. The Company has various vaccines in development including a unique vaccine against Lyme disease. Valneva has operations in Austria, Sweden, the United Kingdom, France, Canada and the U.S. with approximately 490 employees. More information is available at www.valneva.com.

Related

Filed Under: MilTech Tagged With: Biodefense Vaccines, Japanese Encephalitis, vaccine, Valneva

Footer

Recent Posts

  • US preparing a military aid package for India to reduce the country’s dependence on Russian weapons
  • Raytheon Intelligence & Space and Kord team-up to defeat multiple mortars and large drones with Stryker-mounted high-energy laser
  • America and its allies have provided more than 60,000 anti-tank weapons to Ukraine
  • Saab Firings Showcase New Programmable Carl-Gustaf Munition
  • 100 Mistral surface-to-air missile systems for Ukraine from Norway
  • AEROVIRONMENT DONATES OVER 100 QUANTIX RECON UNMANNED AIRCRAFT SYSTEMS TO THE MINISTRY OF DEFENCE OF UKRAINE AND TERRITORIAL FORCES
  • Army Aviation Missions Solutions Summit (Quad A), April 3-5, 2022, Nashville, Tennessee,
  • DIMDEX in Qatar on March 21-23, 2022
  • World Defense Show, 6-9 March 2022, Riyadh, Saudi Arabia
  • Dubai Air Show, November 14-18, 2021

Media Partners

  • Opinion
  • Press Media Release
  • Briefly
  • OPINT
  • VPNW
  • S3H
  • Domain Aftermarkets

Media Partners

  • Technology Conferences
  • Event Sharing Network
  • Cybersecurity Events
  • Event Calendar
  • Calendarial
  • Domain Market Research

Copyright © 2015 DefenseConference.com

Technologies, Market Analysis & Market Research Reports

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT